Shu Hui Chen

Corporate Officer/Principal at WUXI PHARMATECH (CAYMAN) INC. (ADR)

61 year

Health Technology

Consumer Services

Profile

Currently, Shu Hui Chen is Vice President at WuXi AppTec Co., Ltd. and Chief Scientific Officer of Wuxi PharmaTech (Cayman) Inc. In the past he was Research Advisor at Eli Lilly & Co., Associate Director-Chemistry at Vion Pharmaceuticals, Inc. and Senior Research Investigator at Bristol-Myers Squibb Co. Dr. Chen received a doctorate from Yale University and an undergraduate degree from Fudan University.

Shu Hui Chen active positions

Companies	Position	Start
WUXI PHARMATECH (CAYMAN) INC. (ADR)	Corporate Officer/Principal	-

All active positions of Shu Hui Chen

Former positions of Shu Hui Chen

Companies	Position	End
WUXI APPTEC CO., LTD.	Chief Tech/Sci/R&D Officer	2016-03-22
ELI LILLY AND COMPANY	Corporate Officer/Principal	2003-12-31
Vion Pharmaceuticals, Inc. Vion Pharmaceuticals, Inc. BiotechnologyHealth Technology Vion Pharmaceuticals, Inc. develops therapeutics for the treatment of cancer. The company was founded in March 1992 and is headquartered in New Haven, CT.	Corporate Officer/Principal	1996-12-31
BRISTOL-MYERS SQUIBB COMPANY	Corporate Officer/Principal	1994-12-31

See the detail of Shu Hui Chen's experience

Training of Shu Hui Chen

Yale University	Doctorate Degree
Fudan University	Undergraduate Degree

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

See the detail of Shu Hui Chen's experience

Connections

100 +

1st degree connections

1st degree companies

Male

Female

Members of the board

Executives

See the personal network

Linked companies

Listed companies	3
BRISTOL-MYERS SQUIBB COMPANY	Health Technology
ELI LILLY AND COMPANY	Health Technology
WUXI APPTEC CO., LTD.	Health Technology

Private companies	2
Vion Pharmaceuticals, Inc. Vion Pharmaceuticals, Inc. BiotechnologyHealth Technology Vion Pharmaceuticals, Inc. develops therapeutics for the treatment of cancer. The company was founded in March 1992 and is headquartered in New Haven, CT.	Health Technology
Wuxi PharmaTech (Cayman), Inc. Wuxi PharmaTech (Cayman), Inc. Pharmaceuticals: MajorHealth Technology Wuxi PharmaTech (Cayman), Inc. engages in the provision of research and development outsourcing services for the pharmaceutical, biotechnology and medical device industries. It operates through the laboratory services and manufacturing services segments. The laboratory services segment offers pharmaceutical and biotech services including discovery and medicinal chemistry, discovery biology, safety pharmacology, bioanalytical services, process research, formulation and toxicology laboratory services, as well as testing services for biologics, medical devices and combination products. The manufacturing services segment involves the production of intermediates and active pharmaceutical ingredients for or preclinical and clinical trials of small-molecule and commercial products; and biologics. The company was founded by Ge Li, Xiao Zhong Liu, Zhao Hui Zhang and Ning Zhao in 2000 and is headquartered in Shanghai, China.	Health Technology